PLUS: MGM settles breach suits; AWS doesn't trust you with security defaults; A new .NET backdoor; and more Infosec in brief ...

You may have heard in the news that the U.S. Food and Drug Administration will no longer allow the use of FD&C Red Dye No. 3 ...

If you are pregnant or nursing, talk with your health care professional about whether to enroll in pregnancy safety or ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

The US Food and Drug Administration has approved a new, nonopioid pain medication for treating moderate to severe acute pain.

The Cybersecurity and Infrastructure Security Agency and Food and Drug Administration Jan. 30 released notices warning of ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...